現在位置首頁 > 博碩士論文 > 詳目
  • 同意授權
論文中文名稱:美國專利制度下生物印刷科技的專利適格性 [以論文名稱查詢館藏系統]
論文英文名稱:The Patent Eligibility of Bioprint Technology under the United States Patent System [以論文名稱查詢館藏系統]
院校名稱:臺北科技大學
學院名稱:人文與社會科學學院
系所名稱:智慧財產權研究所
畢業學年度:106
畢業學期:第二學期
出版年度:107
中文姓名:陳俊龍
英文姓名:Chanchart Chotiphol
研究生學號:104A48015
學位類別:碩士
語文別:英文
口試日期:2018/01/29
論文頁數:83
指導教授中文名:江雅綺
指導教授英文名:Christy Chiang
口試委員中文名:陳匡正;陳秉訓
口試委員英文名:Kuang-Cheng Chen;Quincy Chen
中文關鍵詞:Bioprint TechnologyPatent EligibilityBiotechnologyIntellectual Property
英文關鍵詞:Bioprint TechnologyPatent EligibilityBiotechnologyIntellectual Property
論文中文摘要:Bioprint is an umbrella term covering a new branch of biotechnology, with one of the most intriguing feature being the ability to artificially synthesize human tissues and organs on demand. With such capability, many are hoping that the Bioprint Technology will be able to address the current organs shortage, while also providing support to future medical researches. Essentially, the advantageous features of the Bioprint Technology have not gone unnoticed, as such for-profit firms and private institutions are eager to quickly obtain IP protections and the temporary monopoly rights to this valuable piece of technology.
Despite the many capabilities, high demand and rapid advancement, the legal system have been slow to keep up. Even though, the intellectual property law was especially created to manage and protect new technological inventions alike Bioprint Technology, but history have shown that biotechnology related inventions often bring about disputes with famous examples including: Diamond v. Chakrabarty, AMP v. Myriad or Mayo v. Prometheus. Under this theory, the issue of patent eligibility for Bioprint Technology still remain highly questionable. Although, the USPTO have already granted a good amount of patents relating to the Bioprint Technology but the legal validity is still yet to be properly defined.
With the patent eligibility issues in mind, this dissertation is aimed to provide the readers with a broad overview of the Bioprint Technology, then proceed to analyze the patent eligibility of the technology within the scope of the United States Patent System, Leahy–Smith America Invents Act (AIA), and with reference to past related cases.
論文英文摘要:Bioprint is an umbrella term covering a new branch of biotechnology, with one of the most intriguing feature being the ability to artificially synthesize human tissues and organs on demand. With such capability, many are hoping that the Bioprint Technology will be able to address the current organs shortage, while also providing support to future medical researches. Essentially, the advantageous features of the Bioprint Technology have not gone unnoticed, as such for-profit firms and private institutions are eager to quickly obtain IP protections and the temporary monopoly rights to this valuable piece of technology.
Despite the many capabilities, high demand and rapid advancement, the legal system have been slow to keep up. Even though, the intellectual property law was especially created to manage and protect new technological inventions alike Bioprint Technology, but history have shown that biotechnology related inventions often bring about disputes with famous examples including: Diamond v. Chakrabarty, AMP v. Myriad or Mayo v. Prometheus. Under this theory, the issue of patent eligibility for Bioprint Technology still remain highly questionable. Although, the USPTO have already granted a good amount of patents relating to the Bioprint Technology but the legal validity is still yet to be properly defined.
With the patent eligibility issues in mind, this dissertation is aimed to provide the readers with a broad overview of the Bioprint Technology, then proceed to analyze the patent eligibility of the technology within the scope of the United States Patent System, Leahy–Smith America Invents Act (AIA), and with reference to past related cases.
論文目次:TABLE OF CONTENTS

Abstract i
Acknowledgement ii
Table of Contents iii
Figures Directory iv
Chapter 1 Dissertation Outlines 1
1.1 Aims of the Dissertation 1
1.2 Dissertation Style 2
Chapter 2 Dissertation Supervision 3
2.1 Supervision 3
2.2 Role of Academic Supervisor 3
2.3 Responsibility of the Authour 5
Chapter 3 Research Methodology 6
3.1 Research Questions 6
3.2 Research Objectives 6
3.3 Research Design 7
3.4 Research Materials 8
3.5 Data Analysis 9
3.6 Research Limitations 9
Chapter 4 Literature Reviews 10
4.1 Purpose of the Literature Reviews 10
4.2 Objectives of the Literature Reviews 10
4.3 Main Subject of the Literature Reviews 10
4.4 Evaluation of Sources 11
4.5 Bioprint Technology Sources Reviews and Discussions 11
4.6 Jefferson Philosophy Literature Reviews 12
4.7 Patent Eligibility Tests Literature Reviews 14
4.8 Human Organism Scope Literature Reviews (AIA Section 33) 16
Chapter 5 Bioprint Technology Overview 19
5.1 History of Bioprint Technology 19
5.2 Bioprinting Process 21
5.3 Main Application of the Bioprint Technology & Organ Transplantation 23
5.4 Other Useful Applications of the Bioprint Technology 25
5.4.1 Regenerative Therapy 25
5.4.2 In Situ Bioprinting 26
5.4.3 Cosmetic Related Applications 27
5.4.5 Medical & Scientific Research 29
Chapter 6 The Analysis for Patent Eligibility of Bioprint Technology 30
6.1 Introduction 30
6.2 The Jefferson Rules 33
6.3 Patent Eligibility Tests 38
6.4 The Scope of Human Organism 64
6.5 Social Impacts of Bioprint Technology 74
6.5.1 Accessibility Issue 74
6.5.2 Moral/Ethical Issue 75
6.5.3 Social Degradation 75
Chapter 7 Conclusions 77
References 79
論文參考文獻:References

1. Ava Caffarini, Directed To or Encompassing a Human Organism: How Section 33 of the America Invents Act May Threaten the Future of Biotechnology, 12 J.MARSHALL REV.INTELL.PROP.L.768 (2013).
2. Bahattin Koç with Yeditepe Un.and Boğaziçi Un., 3D Coaxial Electrohydrodynamic Printing of Multifunctional Scaffolds for Wound Healing and Skin Regeneration (2014), Sabancı Üniversitesi.
3. Benjamin D. Enerson, Protecting Society from Patently Offensive Inventions: The Risk of Reviving the Moral Utility Doctrine, 89CornellL.Rev. 685 (2004)
4. The Biology of Prenatal Development, THE BIOLOGY OF PRENATAL DEVELOPMENT, https://www.ehd.org/resources_bpd_illustrated.php?page=6 (last visited May 23, 2017).
5. Bioprinting Process, ORGANOVO, http://organovo.com/science-technology/bioprinting-process/ (last visited Jul 13, 2017).
6. cDNA (Complementary DNA), Human Genes, http://humangenes.org/cdna-complementary-dna (last visited May 23, 2017).
7. Charron Kira, Bioprinting Skin and Hair: a Good Look for Cosmetic and Healthcare Technology 3D Printing Media Network (2016), https://www.3dprintingbusiness.directory/news/bioprinting-cosmetic-healthcare-technology/ (last visited Jul 13, 2017).
8. Chester S. Chuang & Denys T. Lau, Patenting human genes: The myriad controversy, 32 CLINICAL THERAPEUTICS 2054–2056, 2054-2056 (2010).
9. Christophere Barnatt, Bioprinting Bioprinting - Explaining the Future, http://explainingthefuture.com/bioprinting.html (last visited Jul 13, 2017).
10. Common Health Problems After an Organ Transplant, WEBMD, http://www.webmd.com/a-to-z-guides/organ-transplant-staying-healthy (last visited Jul 13, 2017).
11. Davia Sher, The Top 15 Bioprinters 3D Printing Industry (2015), https://3dprintingindustry.com/news/top-10-bioprinters-55699/ (last visited Jul 13, 2017).
12. Dhakshinamoorthy Sundaramurthi, Sakandar Rauf & Charlotte Hauser, 3D bioprinting technology for regenerative medicine applications, 2 INTERNATIONAL JOURNAL OF BIOPRINTING (2016).
13. Dino J. Ravnic, Ashley N. Leberfinger and Ibrahim T. Ozbolat, Transplantation of Bioprinted Tissues and Organs - Technical and Clinical Challenges and Future Perspectives (2017), Wolters Kluwer Health, Inc.
14. Douglas Robinson & Nina Medlock, Diamond v. Chakrabarty: A Retrospective on 25 Years of Biotech Patents, 17 INTELLECTUAL PROPERTY & TECHNOLOGY LAW JOURNAL 12–15, 12-15 (2005)
15. D.t. Bishop, BRCA1, BRCA2, BRCA3… A myriad of breast cancer genes, 30 EUROPEAN JOURNAL OF CANCER 1738–1739, 1738-1739 (1994).
16. Edmund W. Kitch, The Nature and Function of the Patent System, 20 The Journal of Law and Economics 265–290, 265-290 (1977), http://www-law-nyu-309756845.us-east-1.elb.amazonaws.com/sites/default/files/upload_documents/Kitch.pdf (last visited May 23, 2017).
17. Ethics of therapeutic cloning, 429 NATURE 1–1, 1-1 (2004).
18. Embryo Implantation After IVF, Implantation of Blastocysts & IVF Embryos in Humans, http://www.advancedfertility.com/implantation.htm (last visited May 23, 2017).
19. Embryo Implantation After IVF, Implantation of Blastocysts & IVF Embryos in Humans, http://www.advancedfertility.com/implantation.htm (last visited May 23, 2017).
20. ÉVÈNEMENT, BASF and Poietis sign a research and development agreement on 3D bioprinting technology for advanced skin care applications - Poietis, https://www.poietis.com/en/post-release.php?id=5&view=0 (last visited Jul 13, 2017).
21. Francis A. Carey, Hydrocarbon: Chemical Compound, ENCYCLOPÆDIA BRITANNICA, https://www.britannica.com/science/hydrocarbon/Physical-properties (last visited May 23, 2017).
22. Griffiths Anthony JF, Gene-protein relations An Introduction to Genetic Analysis. 7th edition. (1970), https://www.ncbi.nlm.nih.gov/books/NBK21811/ (last visited May 23, 2017).
23. Hammond John & Gunderman Robert, “Anything Under the Sun Th at Is Made by Man” ...Well, Not Quite, THE LIMITED MONOPOLY 10–10, 10-10 (2009), http://www.patent-innovations.com/documents/200901LimitedMonopoly-AnythingUndertheSun.pdf (last visited Jul 14, 2017).
24. Ibrahim Ozbolat & Hemanth Gudapati, A review on design for bioprinting, 3-4 BIOPRINTING 1–14, 1-14 (2016).
25. Ignacio Poblete-Castro et al., Industrial biotechnology of Pseudomonas putida and related species, 93 APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 2279–2290, 2279-2290 (2012), https://www.ncbi.nlm.nih.gov/pubmed/22350258.
26. J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., 534 U.S. 124.
27. Krench Megan, New Supreme Court Decision Rules That cDNA Is Patentable What It Means for Research and Genetic Testing Scientific American (2013), https://blogs.scientificamerican.com/guest-blog/new-supreme-court-decision-rules-that-cdna-is-patentablewhat-it-means-for-research-and-genetic-testing/ (last visited May 23, 2017).
28. Lee Ventol, Medical Applications for 3D Printing: Current and Projected Uses (2014), NCBI – US National Library of Medicine.
29. Lijie Grace. Zhang, John P. Fisher & Kam W. Leong, 3D bioprinting and nanotechnology in tissue engineering and regenerative medicine (2015).
30. Martin Chaplin, Cellulous explained, https://web.archive.org/web/20051001072830/http://www.lsbu.ac.uk:80/water/hycel.html (last visited May 23, 2017).
31. MEMORANDUM. DATE: September 20, 2011. TO: Patent Examining Corps. __, 242-zº-. FROM: Robert W. Bahr.
32. Meniscus Regenerated with 3-D Printed Implant, Columbia University Medical Center (2014), http://newsroom.cumc.columbia.edu/blog/2014/12/10/3d-printed-meniscus/ (last visited Jul 13, 2017).
33. Murphy, Sean V & Atala, Anthony, 3D bioprinting of tissues and organs, Nature Biotechnology 32, 773–785 (2014)
34. Mossoff Adam, Who Cares What Thomas Jefferson Thought about Patents – Reevaluating the Patent Privilege in Historical Context, 92 Cornell L. Rev. 953 (2007), http://scholarship.law.cornell.edu/clr/vol92/iss5/2 (last visited May 23, 2017).
35. Nazia Mehrban, Gui Zhen Teoh & Martin Anthony Birchall, 3D bioprinting for tissue engineering: Stem cells in hydrogels, 2 INTERNATIONAL JOURNAL OF BIOPRINTING (2016).
36. New England Biolabs, Reverse Transcription, (cDNA Synthesis) Reverse Transcription (cDNA Synthesis) | NEB, https://www.neb.com/applications/cloning-and-synthetic-biology/dna-preparation/reverse-transcription-cdna-synthesis (last visited May 23, 2017).
37. Nieves Cubo, Marta Garcia, Juan F del Cañizo, Diego Velasco, Jose L Jorcano, 3D bioprinting of functional human skin: production and in vivo analysis.
38. Norberto J. Palleroni, The Pseudomonas Story, 12 ENVIRONMENTAL MICROBIOLOGY 1377–1383, 1377-1383 (2010).
39. Norsk Teknisk Museum, DNA and identity: History written in the genes? Norsk Teknisk Museum, https://tekniskmuseum.no/besok-oss/helgeprogram/1399-dna-and-identity-history-written-in-the-genes-22-may (last visited May 23, 2017).
40. Organ Donation Statistics, ORGAN DONATION STATISTICS: WHY BE AN ORGAN DONOR?, https://organdonor.gov/statistics-stories/statistics.html (last visited Jul 13, 2017).
41. Pallab Datta, Bugra Ayan & Ibrahim T. Ozbolat, Bioprinting for vascular and vascularized tissue biofabrication, 51 ACTA BIOMATERIALIA 1–20, 1-20 (2017).
42. Printing a bit of me, THE ECONOMIST (2014), http://www.economist.com/news/technology-quarterly/21598322-bioprinting-building-living-tissue-3d-printer-becoming-new-business (last visited May 23, 2017).
43. Quinn Gene, 30th Anniversary of Diamond v. Chakrabarty (2010), http://www.ipwatchdog.com/2010/06/16/june-16-2010-30th-anniversary-of-diamond-v-chakrabarty/id=11268/ (last visited May 23, 2017).
44. Ramsey Lydia and Lee Samantha, Our DNA is 99.9% the same as the person sitting next to us - and were surprisingly similar to a bunch of other living things, Business Insider (2016), http://www.businessinsider.com/comparing-genetic-similarity-between-humans-and-other-things-2016-5 (last visited May 23, 2017).
45. Sander Rabin, The human use of humanoid beings: chimeras and patent law, Nature Biotechnology 24, 517 - 519 (2006), doi:10.1038/nbt0506-517.
46. Tissues, organs, & organ systems, KHAN ACADEMY, https://www.khanacademy.org/science/biology/principles-of-physiology/body-structure-and-homeostasis/a/tissues-organs-organ-systems (last visited May 24, 2017).
47. Therapeutic Cloning, New England J Med 2002; 347:1619-1622, November 14, 2002, DOI: 10.1056/NEJM200211143472014.
48. Thrikell Sarah, An Interview with Professor Makoto Nakamura, International BIOPRINTING Congress, Journal of Materials Chemistry – Royal Society of Chemistry, http://blogs.rsc.org/jm/2014/07/02/an-interview-with-professor-makoto-nakamura/?doing_wp_cron=1499932911.8655970096588134765625 (last visited Jul 13, 2017).
49. Thomas B. Kepler, Colin Crossman & Robert Cook-Deegan, Metastasizing patent claims on BRCA1, 95 GENOMICS 312–314, 312-314 (2010).
50. Thomas Jefferson to Isaac McPherson, ARTICLE 1, SECTION 8, CLAUSE 8: THOMAS JEFFERSON TO ISAAC MCPHERSON, http://press-pubs.uchicago.edu/founders/documents/a1_8_8s12.html (last visited May 23, 2017).
51. Thomas W. Cole, Why Most Patents Are Invalid, 14 IEEE ENGINEERING MANAGEMENT REVIEW 46–48, 46-48 (1986).
52. Transplantation, UNOS, https://www.unos.org/transplantation/ (last visited Jul 13, 2017).
53. Vijayavenkataraman S., Lu W.f. & Fuh J.y.h., 3D bioprinting – An Ethical, Legal and Social Aspects (ELSA) framework, 1-2 BIOPRINTING 11–21, 11-21 (2016).
54. What Is Breast Cancer?, American Cancer Society, https://www.cancer.org/cancer/breast-cancer/about/what-is-breast-cancer.html (last visited May 23, 2017).
55. What Is Cancer?, National Cancer Institute, https://www.cancer.gov/about-cancer/understanding/what-is-cancer (last visited May 23, 2017).
56. What does it mean to be human?, Genetics | The Smithsonian Institutions Human Origins Program (2010), http://humanorigins.si.edu/evidence/genetics (last visited May 23, 2017).
57. What You Need to Know About Organ Transplants, WEBMD, http://www.webmd.com/a-to-z-guides/organ-transplant-overview#1 (last visited Jul 13, 2017).
58. Wei Long Ng et al., Skin Bioprinting: Impending Reality or Fantasy?, 34 TRENDS IN BIOTECHNOLOGY 689–699, 689-699 (2016).
59. 149 Cong. Rec. E2417 (2003) (statement of Hon. Dave Weldon of Florida).
論文全文使用權限:同意授權於2018-02-12起公開